Wolff, Ladislaia
Steindl, Ariane
Popov, Petar
Dieckmann, Karin
Gatterbauer, Brigitte
Widhalm, Georg
Berghoff, Anna Sophie
Preusser, Matthias
Raderer, Markus
Kiesewetter, Barbara
Funding for this research was provided by:
Medical University of Vienna
Article History
Received: 31 January 2023
Accepted: 17 April 2023
First Online: 23 May 2023
Declarations
:
: The authors report no relevant conflicts of interest for this paper. LW has no conflicts of interest to declare. AS received travel support from Merck. PP has no conflicts of interest to declare- KD has no conflicts of interest to declare. BG has no conflicts of interest to declare. GW has no conflicts of interest to declare. MP received honoraria for lectures, consultation or advisory board participation from the following for-profit companies: Bayer, Bristol-Myers Squibb, Novartis, Gerson Lehrman Group (GLG), CMC Contrast, GlaxoSmithKline, Mundipharma, Roche, BMJ Journals, MedMedia, Astra Zeneca, AbbVie, Lilly, Medahead, Daiichi Sankyo, Sanofi, Merck Sharp & Dome, Tocagen, Adastra, Gan & Lee Pharmaceuticals. MR received honoraria for lectures or advisory board participation from the following for-profit companies (all outside of the submitted work): Celgene/BMS, Ipsen, Novartis, Roche, Eisai, Eli Lilly. ASB has research support from Daiichi Sankyo, Roche and honoraria for lectures, consultation or advisory board participation from Roche Bristol-Meyers Squibb, Merck, Daiichi Sankyo, AstraZeneca, CeCaVa as well as travel support from Roche, Amgen and AbbVie. BK received honoraria for lectures or advisory board participation from the following for-profit companies (all outside of the submitted work): AAA, Boehringer Ingelheim, Ipsen, Novartis, MSD, Eli Lilly, Janssen Cilag.